CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma

Clinical trial NCT00634751 · COMPLETED

Trial details

NCT number: NCT00634751
Sponsor: University of Wisconsin, Madison
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Neoplasms Bile Duct Neoplasms

Start date: 2008-02-01
Primary completion: 2010-07-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.